Pharmaceutical Analysis, Technology and Biopharmaceuticals

Entry requirements

Minimum 2:1 first degree (or equivalent) in a Chemistry or Biochemistry-related discipline.

In order to meet the academic entry requirements for this programme you should have a minimum 2:1 undergraduate degree with a final mark of at least 60% or above in the UK marking scheme. If you are still studying you should be achieving an average of at least 60% or above in the UK marking scheme.

Candidates with a 2:2 or equivalent may be considered if they have substantial relevant work experience.

Months of entry

September

Course content

Better medicines can change lives. Here at King’s, our renowned pharmaceutical science and pharmacology research is helping us develop new drugs, new policies and new ways of working. This is your chance to immerse yourself in the groundbreaking work happening here and take on your own project at the end of the course.

We designed this MSc to improve your skills for a career in the pharmaceutical and biopharmaceutical industry or conducting further research with a PhD. You’ll work with leading experts in our labs, using the latest techniques and instruments.

• We are ranked 13th in the world for Pharmacy & Pharmacology (QS World University Rankings by Subject 2020).
• Well-equipped laboratories give you lots of ‘hands-on’ time for a range of modern techniques and instruments.
• Located in the centre of London in an institute that is renowned for its international research profile.
• Opportunity to undertake an extended 6 months project of your choosing in the labs of internationally- rated scientists.
• Complementary attendance to a Joint Pharmaceutical and Analysis Group symposium at the Royal Society of Chemistry in London to meet with leading scientists from major pharmaceutical industries, regulatory bodies and to hear the latest discussions on pharmaceutical analysis and regulatory hot topics.
• A wide range of career options including pharmaceutical companies, biotech industries, regulatory bodies and research.